These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 22286119)
21. Mucin expression in gastric cancer: reappraisal of its clinicopathologic and prognostic significance. Kim DH; Shin N; Kim GH; Song GA; Jeon TY; Kim DH; Lauwers GY; Park DY Arch Pathol Lab Med; 2013 Aug; 137(8):1047-53. PubMed ID: 23899060 [TBL] [Abstract][Full Text] [Related]
22. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Su YC; Hsu YC; Chai CY Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563 [TBL] [Abstract][Full Text] [Related]
23. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Lee MJ; Lee HS; Kim WH; Choi Y; Yang M Mod Pathol; 2003 May; 16(5):403-10. PubMed ID: 12748245 [TBL] [Abstract][Full Text] [Related]
24. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. Zhou H; Schaefer N; Wolff M; Fischer HP Am J Surg Pathol; 2004 Jul; 28(7):875-82. PubMed ID: 15223956 [TBL] [Abstract][Full Text] [Related]
25. Human pancreatic mucinous cystadenoma is characterized by distinct mucin, cytokeratin and CD10 expression compared with intraductal papillary-mucinous adenoma. Handra-Luca A; Fléjou JF; Rufat P; Corcos O; Belghiti J; Ruszniewski P; Degott C; Bedossa P; Couvelard A Histopathology; 2006 Jun; 48(7):813-21. PubMed ID: 16722930 [TBL] [Abstract][Full Text] [Related]
26. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer. Wakatsuki K; Yamada Y; Narikiyo M; Ueno M; Takayama T; Tamaki H; Miki K; Matsumoto S; Enomoto K; Yokotani T; Nakajima Y J Surg Oncol; 2008 Aug; 98(2):124-9. PubMed ID: 18521835 [TBL] [Abstract][Full Text] [Related]
27. Cytokeratin 7/20 and mucin expression patterns in oesophageal, cardia and distal gastric adenocarcinomas. Gulmann C; Counihan I; Grace A; Patchett S; Leen E; Leader M; Kay E Histopathology; 2003 Nov; 43(5):453-61. PubMed ID: 14636271 [TBL] [Abstract][Full Text] [Related]
28. Modified classification for adenocarcinoma of the gastro-oesophageal junction. Shearer CJ; Going JJ; Neilson LJ; Stuart RC ANZ J Surg; 2007 Jul; 77(7):544-9. PubMed ID: 17610690 [TBL] [Abstract][Full Text] [Related]
29. [Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma]. Zhao SM; Zhu XZ; Ji Y; Hou J Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):749-53. PubMed ID: 19094709 [TBL] [Abstract][Full Text] [Related]
30. The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters. Oz Puyan F; Can N; Ozyilmaz F; Usta U; Sut N; Tastekin E; Altaner S J Cancer Res Clin Oncol; 2011 Dec; 137(12):1749-62. PubMed ID: 21909647 [TBL] [Abstract][Full Text] [Related]
31. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Cai YC; Banner B; Glickman J; Odze RD Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943 [TBL] [Abstract][Full Text] [Related]
32. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas. Gyure KA; Morrison AL Mod Pathol; 2000 Jun; 13(6):638-43. PubMed ID: 10874668 [TBL] [Abstract][Full Text] [Related]
33. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody. Bayrak R; Haltas H; Yenidunya S Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990 [TBL] [Abstract][Full Text] [Related]
34. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype. Tot T Med Sci Monit; 2004 May; 10(5):BR139-43. PubMed ID: 15114262 [TBL] [Abstract][Full Text] [Related]
35. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas. Gürbüz Y; Kahlke V; Klöppel G Virchows Arch; 2002 May; 440(5):505-11. PubMed ID: 12021925 [TBL] [Abstract][Full Text] [Related]
36. Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract. Cabibi D; Licata A; Barresi E; Craxì A; Aragona F Pathol Res Pract; 2003; 199(2):65-70. PubMed ID: 12747467 [TBL] [Abstract][Full Text] [Related]
37. [Value of cytokeratin 7 and 20 for the diagnosis of cerebral metastases of adenocarcinoma: study of 78 cases]. Fernandez C; Liprandi A; Bouvier-Labit C; Figarella-Branger D Ann Pathol; 2001 Apr; 21(2):129-35. PubMed ID: 11373582 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical distinction of intestinal-type sinonasal adenocarcinoma from metastatic adenocarcinoma of intestinal origin. Resto VA; Krane JF; Faquin WC; Lin DT Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):59-64. PubMed ID: 16466101 [TBL] [Abstract][Full Text] [Related]
39. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications. Lee OJ; Kim HJ; Kim JR; Watanabe H Oncol Rep; 2009 Feb; 21(2):387-93. PubMed ID: 19148512 [TBL] [Abstract][Full Text] [Related]
40. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Tot T Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]